On November 4, 2020 at the virtual AAPS conference, the role of model informed drug development practices as applied to COVID was discussed by Dr. Craig Rayner, President of Integrated Drug Developmen...
Events
Webinar: Controlled Human Infection Challenge Studies: Lessons from Malaria towards COVID-19
Controlled Human Infection Challenge Studies which involve the deliberate infection of healthy volunteers are well established during the clinical development of vaccines for influenza, typhoid, chole...
Webinar on May 14: Model-informed Drug Repurposing – Applications for COVID-19
The global scientific community’s scramble to rapidly find therapeutics for COVID-19 has been reassuring, but unfortunately also chaotic. There are now almost 700 clinical trials conducted, planned ...
April 23rd Virtual Panel Discussion: COVID-19: Trials, Designs and Tools for Promising Results
In response to the COVID-19 pandemic, there are over 500 global clinical trials taking place to develop life-saving treatments and vaccines for patients. In these unprecedented times, sponsors must ut...
May 6 Webinar: COVID-19: Building for Today and Tomorrow – Therapeutic Considerations for Children and Pregnant Women
There are unique considerations to factor in treating COVID-19 in children and pregnant women. While COVID-19 disease among children have been less severe than those in adults, the youngest appear to ...
Event: Accelerating Therapeutics for COVID-19 Webinar on April 8
Speaker(s): Dr. Dan Hartman, Director of Integrated Development, Bill & Melinda Gates Foundation Dr. Steven Kern, Deputy Director of Quantitative Sciences, Bill & Melinda Gates Foundation Dr...